Bal Pharma sets eyes on Mumbai market
Bal Pharma, the city-based pharma company, is extending its coverage in Mumbai by increasing its workforce by three times for its main division and simultaneously doubling it for its cardiac division Servetus.

Purol-H gets seal of approval from IICB
PUROL-H, a premium herbal product of Kolkata based Herbochem Remedies India (Pvt) Ltd for dermatological diseases, has been recently chemically tested for its bio-efficacy and analytical evaluation of herbal active molecules at the city-based Indian Institute of Chemical Biology (IICB).

Jagsonpal to expand LycoRed reach
AFTER the test-launch in Delhi, the New Delhi-based Jagsonpal Pharmaceuticals Ltd is making plans to make LycoRed reach different parts of the country.

Ranbaxy’s Augmentin market share to grow
Ranbaxy Laboratories Ltd (RLL) is expected to start gaining market-share in generic Augmentin (amoxicillin/ clavulanic acid) in the next 2-3 weeks as GSK has lost its trade secret case in a US court, according to analysts here.

Corporate Scan

Abbott India: Insulin price cut is a constraint
The change of management at Abbott India (AIL) (formerly) has not brought cheers to investors as the company’s net sale grew marginally by 2.2 per cent to Rs 82 crore during the first quarter to February 2003.

A long way to go to attain global standards
INDIAN pharma companies have woken up to the relevance of research. It is the only imperative that can sustain them in the future.